Cleavage of ultra-large von Willebrand factor by ADAMTS-13 under flow conditions

被引:124
|
作者
Dong, JF [1 ]
机构
[1] Baylor Coll Med, Thrombosis Res Sect, Dept Med, Houston, TX 77030 USA
关键词
ADAMTS-13; proteolysis; shear stress; von Willebrand factor;
D O I
10.1111/j.1538-7836.2005.01360.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
von Willebrand factor (VWF) is a critical ligand for platelet adhesion and aggregation. It is synthesized and released as multimers composed of various numbers of monomers. When first released from the storage granules of endothelial cells, VWF multimers are rich in the ultra-large (UL) forms that spontaneously bind the GP Ib-IX complex and aggregate platelets. These prothrombotic ULVWF multimers are rapidly cleaved by the metalloprotease ADAMTS-13 (A Disintegrin and Metalloprotease with ThromboSpondin motif) to smaller and much less active forms. Recently, several methods have been developed to measure ADAMTS-13 activity in vitro and to link its deficiency to thrombotic thrombocytopenic purpura. Correlations between the structure and functions of the metalloprotease have also been extensively studied using recombinant technologies. However, questions remain regarding the proper substrate for the metalloprotease, the time and location of ULVWF proteolysis, and the role Of fluid shear stress. In this brief review, we have discussed a potential model for ULVWF proteolysis by ADAMTS-13 in vivo. In this model, ULVWF is anchored to the surface of endothelial cells to form string-like structures under fluid shear stress. Such an elongated conformation facilitates ULVWF cleavage by exposing either the cleavage or binding sites for the metalloprotease. When ADAMTS-13 is deficient, the uncleaved ULVWF accumulates in plasma and on endothelial cells to capture platelets. This leads to platelet aggregation and thromboembolism. Dissecting the process of ULVWF proteolysis is important for not only understanding the pathophysiology of thrombotic rnicroangiopathies, but also developing more effective means to treat these deadly diseases.
引用
收藏
页码:1710 / 1716
页数:7
相关论文
共 50 条
  • [31] Cleavage of von Willebrand factor by ADAMTS-13 in vitro:: effect of temperature and barium ions on the proteolysis kinetics
    Perutelli, P
    Amato, S
    Molinari, AC
    BLOOD COAGULATION & FIBRINOLYSIS, 2005, 16 (08) : 607 - 611
  • [32] Quantification of Von Willebrand Factor Cleavage by adamts-13 in Patients Supported by Left Ventricular Assist Devices
    Zhou, Yong
    Qin, Shizhen
    Hilton, Tristan
    Tang, Li
    Cruz, Miguel
    Hernandez, Ruben
    Moake, Joel L.
    Tian, Qiang
    Frazier, O. H.
    Dong, Jing-fei
    Nascimbene, Angelo
    ASAIO JOURNAL, 2017, 63 (06) : 849 - 853
  • [33] Changes in von Willebrand factor and ADAMTS-13 in patients following arthroplasty
    Liu, Ling
    Ling, Jing
    Ma, Zhenni
    Yuan, Quan
    Pan, Jun
    Yang, Huilin
    MOLECULAR MEDICINE REPORTS, 2015, 11 (04) : 3015 - 3020
  • [34] Multi-step binding of ADAMTS-13 to von Willebrand factor
    Feys, H. B.
    Anderson, P. J.
    Vanhoorelbeke, K.
    Majerus, E. M.
    Sadler, J. E.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (12) : 2088 - 2095
  • [35] Upregulation of von Willebrand Factor, von Willebrand Factor propeptide and ADAMTS-13 in end stage renal disease
    Bansal, V
    Davis, R.
    Litinas, E.
    Hoppensteadt, D.
    Thethi, I
    Fareed, J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 207 - 207
  • [36] Modeling the cleavage of von Willebrand factor by ADAMTS13 protease in shear flow
    Huisman, Brooke
    Hoore, Masoud
    Gompper, Gerhard
    Fedosov, Dmitry A.
    MEDICAL ENGINEERING & PHYSICS, 2017, 48 : 14 - 22
  • [37] ADAMTS-13 and bleeding phenotype in von Willebrand disease
    Boender, Johan
    Nederlof, Angelique
    Meijer, Karina
    Mauser-Bunschoten, Evelien P.
    Cnossen, Marjon H.
    Fijnvandraat, Karin
    van der Bom, Johanna G.
    de Meris, Joke
    Gorkom, Britta A. P. Laros-van
    van Galen, Karin P. M.
    Eikenboom, Jeroen
    de Maat, Moniek P. M.
    Leebeek, Frank W. G.
    RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS, 2020, 4 (08) : 1331 - 1339
  • [38] ADAMTS-13 and von Willebrand factor predict venous thromboembolism in patients with cancer
    Pepin, M.
    Kleinjan, A.
    Hajage, D.
    Buller, H. R.
    Di Nisio, M.
    Kamphuisen, P. W.
    Salomon, L.
    Veyradier, A.
    Stepanian, A.
    Mahe, I.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2016, 14 (02) : 306 - 315
  • [39] von Willebrand factor cleaving protease (ADAMTS-13) and ADAMTS-13 neutralizing autoantibodies in 100 patients with thrombotic thrombocytopenic purpura
    Peyvandi, F
    Ferrari, S
    Lavoretano, S
    Canciani, MT
    Mannucci, PM
    BRITISH JOURNAL OF HAEMATOLOGY, 2004, 127 (04) : 433 - 439
  • [40] Opposite changes of ADAMTS-13 and von Willebrand factor after cardiac surgery
    Mannucci, PM
    Parolari, A
    Canciani, MT
    Alemanni, F
    Camerat, M
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (02) : 397 - 399